US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

EQ

Equillium (EQ)

Equillium Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EQ

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EQ	Equillium Inc
2024/05/10	05 : 01	Business Wire	Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights	NASDAQ:EQ	Equillium Inc
2024/05/07	21 : 00	Business Wire	Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists	NASDAQ:EQ	Equillium Inc
2024/04/03	21 : 00	Business Wire	Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EQ	Equillium Inc
2024/04/01	21 : 00	Business Wire	Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis	NASDAQ:EQ	Equillium Inc
2024/03/26	05 : 01	Business Wire	Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights	NASDAQ:EQ	Equillium Inc
2024/03/22	21 : 00	Business Wire	Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference	NASDAQ:EQ	Equillium Inc
2024/03/09	07 : 35	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2024/03/09	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/02/24	07 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/02/24	07 : 09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EQ	Equillium Inc
2024/02/22	20 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/01/04	08 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2024/01/04	08 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2024/01/04	08 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQ	Equillium Inc
2023/12/21	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/12/21	22 : 00	Business Wire	Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease	NASDAQ:EQ	Equillium Inc
2023/11/21	01 : 23	PR Newswire (US)	EQ Bank Card launches in Québec as Carte Banque EQ	NASDAQ:EQ	Equillium Inc
2023/11/21	01 : 23	PR Newswire (Canada)	EQ Bank Card launches in Québec as Carte Banque EQ	NASDAQ:EQ	Equillium Inc
2023/11/13	23 : 00	Business Wire	Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology	NASDAQ:EQ	Equillium Inc
2023/11/09	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EQ	Equillium Inc
2023/11/09	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/11/09	06 : 01	Business Wire	Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates	NASDAQ:EQ	Equillium Inc
2023/11/06	22 : 00	Business Wire	Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology	NASDAQ:EQ	Equillium Inc
2023/10/19	21 : 00	Business Wire	Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology	NASDAQ:EQ	Equillium Inc
2023/10/16	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/10/16	21 : 00	Business Wire	Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium	NASDAQ:EQ	Equillium Inc
2023/10/06	06 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2023/10/06	06 : 23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EQ	Equillium Inc
2023/10/03	21 : 00	Business Wire	Equillium to Host Analyst & Investor Day	NASDAQ:EQ	Equillium Inc

Showing the most relevant articles for your search:NASDAQ:EQ

1 2 3 4 5 6 7 8 9 10 次へ >>

Financial Select Sector

Deutsche Telekom (QX)

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Bank of America

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約